Latest News - HCA Healthcare
Top Corporates Hub
HCA Healthcare
Outset Medical Q2 Earnings Call Highlights
07.08.2026 06:04
Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare. Chair and Chief Executive Of
Hospital giant flags $400 million hit from policy change
29.07.2026 02:03
HCA Healthcare (HCA), the United States' largest hospital chain, beat Wall Street on both revenue and profit for the second quarter, then watched its own stock fall anyway. The reason sits inside a single line item: a roughly $400 million pre-tax hit tied to patients losing health insurance ...
HCA Healthcare Q2 Earnings Call Highlights
24.07.2026 16:03
HCA Healthcare (NYSE:HCA) said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured popu
HCA Q2 Earnings Beat on Strong Admissions, 2026 Outlook Revised
24.07.2026 15:47
HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.
HCA Healthcare, Inc. (HCA) Q2 2026 Earnings Call Transcript
24.07.2026 15:20
HCA Healthcare, Inc. (HCA) Q2 2026 Earnings Call July 24, 2026 10:00 AM EDTCompany ParticipantsFrank Morgan - Vice President of Investor RelationsSamuel...
Why Tenet Healthcare Stock Is Surging 23% Today While This Rival Lags Behind
24.07.2026 13:59
Tenet and HCA Healthcare present Wall Street with different pictures of their operations as the companies report second-quarter earnings.
HCA (HCA) Reports Q2 Earnings: What Key Metrics Have to Say
24.07.2026 13:30
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HCA Healthcare (HCA) Q2 Earnings Surpass Estimates
24.07.2026 12:40
HCA (HCA) delivered earnings and revenue surprises of +0.26% and 0.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
HCA Healthcare’s (NYSE:HCA) Q2 CY2026 Sales Top Estimates
24.07.2026 12:02
Hospital operator HCA Healthcare (NYSE:HCA) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 8.7% year on year to $20.23 billion. The company expects the full year’s revenue to be around $78.25 billion, close to analysts’ estimates. Its GAAP profit of $7.62 per share was 2.2% above analysts’ consensus estimates.
HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth
24.07.2026 11:33
HCA Healthcare beat Q2 revenue and earnings estimates as admissions rose, while a payer mix shift and lower surgical volumes weighed on results.
HCA Healthcare Reports Second Quarter 2026 Results
24.07.2026 11:30
NASHVILLE, Tenn., July 24, 2026--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026.
HCA Healthcare Exec Says Long-Term Patient Volume Growth Expected At 2%-3%, Supported By Market Demographics And Population Growth; Original Assumption Around Declining Utilization For Patients That Become Uninsured Due To The Loss Of Insurance Cover...
24.07.2026 10:30
-Conference Call
HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $28.70-$30.50 vs $29.70 Est; Affirms FY2026 Sales Guidance of $77.000B-$79.500B vs $78.457B Est
24.07.2026 07:31
HCA Healthcare (NYSE:HCA) affirms FY2026 GAAP EPS guidance from $28.70-$30.50 to $28.70-$30.50 vs $29.70 analyst estimate. Affirms FY2026 sales outlook from $77.000 billion-$79.500 billion to $77.000 billion-$79.500
HCA Healthcare Q2 Adj. EPS $7.59 Beats $7.02 Estimate, Sales $20.230B Beat $19.400B Estimate
24.07.2026 07:30
HCA Healthcare (NYSE:HCA) reported quarterly earnings of $7.59 per share which beat the analyst consensus estimate of $7.02 by 8.12 percent. This is a 10.96 percent increase over earnings of $6.84 per share from the
HCA Healthcare (HCA) Q2 Earnings Report Preview: What To Look For
23.07.2026 03:56
Hospital operator HCA Healthcare (NYSE:HCA) will be announcing earnings results this Friday morning. Here’s what to expect.
HCA Healthcare (HCA) Stock Sees Modest Fair Value Cut As Policy Risks Temper Growth Views
15.07.2026 11:13
HCA Healthcare is in focus after its modeled fair value was trimmed from US$503.57 to US$490.29, reflecting updated assumptions in the latest analyst work. This shift lines up with recent research that leans more cautious on long term growth and policy risk, even as some analysts still point to support from core operations and certain volume trends. As you read on, you will see how these pricing updates fit into the broader Street narrative on HCA Healthcare and what to watch to keep up with...
Barclays Downgrades HCA Healthcare (HCA) – Here’s Why
15.07.2026 09:08
HCA Healthcare, Inc. (NYSE:HCA) is one of the top cheap blue chip stocks to buy according to Wall Street analysts. Barclays downgraded HCA Healthcare, Inc. (NYSE:HCA) to Equal Weight from Overweight on July 8, bringing the price target on the stock down to $427 from $496. The firm told investors that following a strong three-year […]
HCA Healthcare's Warning Prices In All The Bad News (Upgrade)
15.07.2026 06:00
HCA Healthcare stock is upgraded to "Buy" after underperformance. Here's what investors need to know.
HCA Healthcare's Warning Prices In All The Bad News (Upgrade)
15.07.2026 06:00
HCA Healthcare stock is upgraded to "Buy" after underperformance. Here's what investors need to know.
What Makes HCA Healthcare (HCA) a Compelling Investment Bet?
13.07.2026 14:56
Right Tail Capital, an investment management company, recently published its Q2 2026 investor letter. A copy of the letter can be downloaded here. The letter stated that currently, many businesses are attractively valued in the market due to multiple reasons, such as being labelled as an AI loser or being in the cycle. The firm […]